Your Runny Nose Won't Stop. Here's the Biological Reason.

HLA-DQ2 is part of your MHC (Major Histocompatibility Complex), the system your immune cells use to recognize what’s foreign and what’s self. Think of it as the passport checker at your airway’s border. When your immune cells encounter a particle, they present it to HLA-DQ2. HLA-DQ2 decides: threat or harmless? If the signal is “threat,” your immune system launches a Th2 response, flooding your airways with inflammatory cytokines and histamine.

Carried by approximately 25 to 30 percent of people with European ancestry, HLA-DQ2 typing can be protective in some contexts but problematic in others. The problem emerges when HLA-DQ2 triggers aggressive immune recognition against particles that shouldn’t provoke a response. Your nose becomes a hypervigilant security checkpoint, flagging pollen, dust mites, and other harmless particles as dangerous invaders. This drives a cascade of Th2 immune activation, mast cell degranulation, and persistent histamine release.

You experience this as a runny nose that worsens in spring when pollen is high, or flares around dust. Your nose doesn’t just react to obvious allergens; it overreacts to minor irritants. You might wake up with sinus pressure that builds throughout the day, then drains at night. Nasal sprays and antihistamines help temporarily, but the moment you stop using them, the cycle resumes.

Interleukin-13 is a cytokine released by your immune cells when they’ve decided something is dangerous. It’s one of the chief architects of Th2 immune responses. When IL-13 binds to receptors in your airway lining, it triggers mucus-secreting cells to flood your nasal passages and drives eosinophilic (allergy-type) inflammation deep in your tissues.

Carried in variants by roughly 30 to 35 percent of the population, the IL13 gene can amplify airway reactivity beyond what would normally occur. Elevated IL-13 activity doesn’t just cause inflammation; it physically remodels your airway. Your mucus-producing cells become hyperactive and start cranking out fluid even when there’s no real threat present. Your airway tissue swells. The lining becomes hypersensitive to irritation. What used to be a minor trigger now sparks a full immune response.

You notice this as a persistently runny or stuffy nose that doesn’t match your allergy test results. You produce thick mucus, sometimes clear, sometimes slightly opaque. Your nose feels full even when you’re not congested. Post-nasal drip becomes a constant background annoyance. You might clear your throat repeatedly throughout the day. Nasal decongestants provide temporary relief but don’t address the underlying IL-13 driven inflammation.

Interleukin-4 is the master switch that flips your immune system into allergic mode. It’s released by activated immune cells and tells your B cells to produce IgE (immunoglobulin E), the antibody responsible for allergic reactions. IL-4 also recruits more Th2 helper cells, creating a self-reinforcing loop of allergic sensitization.

Present in variants in roughly 30 percent of the population, the IL4 gene can predispose you to a Th2-skewed immune response even in the absence of a true allergen. Your immune system is biased toward treating harmless particles as dangerous and mounting allergic responses instead of tolerant ones. This doesn’t mean you’ll test positive on allergy panels. It means your immune cells are primed to react allergically, and your airways are the first place that reaction shows up.

You experience this as seasonal or perennial nasal symptoms that don’t fully correlate with any identified allergen. You sneeze in clusters. Your nose itches internally. You feel like you have allergies, but nobody can identify what you’re allergic to. You might have tried antihistamines and found they help a little, but not enough. You suspect your allergies are getting worse with age or season, but your allergy tests stay negative or show only minor sensitivities.

Filaggrin is a structural protein that builds and maintains the outer layers of your skin and airway lining. It acts as a mortar between cells, creating a tight barrier that keeps irritants out and moisture in. Think of it as the caulking in the joints of your airway walls. Without strong filaggrin, those joints are loose, and particles slip through that shouldn’t.

Carried in loss-of-function variants by roughly 10 percent of people with European ancestry, FLG mutations compromise barrier integrity. Your airway lining becomes permeable; allergens, pollutants, and irritant molecules penetrate deeper into your tissues and activate your immune system more easily than they should. This is called the “leaky airway” phenomenon. It’s not visible and it’s not a condition doctors typically test for, but it’s a primary driver of persistent rhinitis.

You notice this as a runny nose triggered by seemingly innocuous things: temperature changes, dry air, perfume, air pollution, or even exercise. Your nose drips more in winter or in very dry climates. You’ve tried humidifiers, and they help a little, but the symptoms return once you’re back in normal conditions. You might have eczema or very dry, sensitive skin as well, because FLG variants affect both skin and airway barriers. Your nasal lining feels irritated and tender, not inflamed.

Toll-like receptor 4 (TLR4) is a pattern recognition receptor on your immune cells. It’s designed to detect bacterial endotoxin (lipopolysaccharide, or LPS) and trigger an immediate immune response. TLR4 is your first line of defense against gram-negative bacteria. When TLR4 works properly, you can fight off infections quickly. When it doesn’t, bacteria and their toxins linger longer in your tissues.

Present in variants in roughly 10 percent of people with European ancestry, the TLR4 D299G mutation reduces your ability to recognize bacterial LPS. Your innate immune system responds more slowly to bacterial challenges, and in some cases, it overcompensates once it finally mounts a response. This can create cycles where secondary bacterial infections complicate viral rhinitis, or where bacterial colonization (often Staphylococcus aureus) in the nasal cavity triggers chronic inflammation.

You notice this as runny nose symptoms that sometimes clear quickly and sometimes drag on for weeks. You might get recurrent sinus infections or notice that your nasal drip becomes thick and yellow-green, suggesting bacterial overgrowth. You’re more susceptible to respiratory infections generally. When you do get sick, it takes longer to recover. Your nasal symptoms might improve briefly with antibiotics, then return once you stop treatment.

The vitamin D receptor (VDR) is the protein that allows your cells to respond to vitamin D. Vitamin D itself acts as a hormone; it signals your immune cells to develop tolerance toward harmless particles and to reduce inflammatory responses. VDR is the lock that vitamin D’s key fits into. Without a functional VDR, even high vitamin D levels can’t properly activate immune tolerance, leaving your immune system stuck in an aggressive posture.

Present in several common variants (FokI, BsmI, ApaI, TaqI), VDR variants are found in roughly 40 to 50 percent of the population depending on ancestry. The Ff genotype of FokI produces a shorter, more active receptor; the FF genotype produces a longer, less active one. People with less active VDR variants need higher vitamin D levels to achieve the same immune-regulating effects, and they remain prone to Th2-skewed immune responses even with adequate vitamin D supplementation.

You experience this as allergic symptoms that don’t fully resolve even when you supplement with vitamin D. Your nose is particularly bad in winter or when you spend less time outdoors. You might have noticed that your allergic symptoms correlate with seasons (worse in darker months). You could have multiple food sensitivities or environmental sensitivities that suggest an over-reactive immune system. Your immune symptoms (runny nose, frequent colds, slow recovery) improve when you get consistent sun exposure, but relapse when you don’t.